You are here

  • Home
  • Archive
  • Volume 7, Issue 1
  • Use and outcomes of targeted therapies in early and metastatic HER2-positive breast cancer in Australia: protocol detailing observations in a whole of population cohort

Citation Tools

Article menu

Download PDFPDF

XML
Oncology
Protocol
Use and outcomes of targeted therapies in early and metastatic HER2-positive breast cancer in Australia: protocol detailing observations in a whole of population cohort

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Daniels B, Lord SJ, Kiely BE On behalf of the HER2 therapy observational study (HER2-OBS) investigators, et al
Use and outcomes of targeted therapies in early and metastatic HER2-positive breast cancer in Australia: protocol detailing observations in a whole of population cohort
BMJ Open 2017;7:e014439. doi: 10.1136/bmjopen-2016-014439